Latest News by Industry
Esperion Therapeutics, Inc. [ESPR] has reported fiscal Q1 loss of $61.70 million.
On a per-share basis, the DE based company said its diluted earnings are $0.79.
The Pharmaceutical Preparations firm posted revenue of $24.30 million in this period.
Also Read: